Does LISINOPRIL Cause Product dose omission issue? 251 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 251 reports of Product dose omission issue have been filed in association with LISINOPRIL (Lisinopril). This represents 0.7% of all adverse event reports for LISINOPRIL.
251
Reports of Product dose omission issue with LISINOPRIL
0.7%
of all LISINOPRIL reports
6
Deaths
102
Hospitalizations
How Dangerous Is Product dose omission issue From LISINOPRIL?
Of the 251 reports, 6 (2.4%) resulted in death, 102 (40.6%) required hospitalization, and 3 (1.2%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LISINOPRIL. However, 251 reports have been filed with the FAERS database.
What Other Side Effects Does LISINOPRIL Cause?
Angioedema (5,370)
Drug hypersensitivity (3,779)
Cough (2,527)
Completed suicide (2,246)
Drug ineffective (2,208)
Acute kidney injury (2,022)
Dyspnoea (1,856)
Dizziness (1,758)
Hypotension (1,750)
Fatigue (1,549)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which LISINOPRIL Alternatives Have Lower Product dose omission issue Risk?
LISINOPRIL vs LISOCABTAGENE MARALEUCEL
LISINOPRIL vs LITHIUM
LISINOPRIL vs LIXISENATIDE
LISINOPRIL vs LOBAPLATIN
LISINOPRIL vs LOFEXIDINE